ABROGATION OF THE SUPPRESSIVE EFFECTS OF DEXAMETHASONE BY PKC ACTIVATION OR CD28 TRIGGERING

Citation
Ewp. Nijhuis et al., ABROGATION OF THE SUPPRESSIVE EFFECTS OF DEXAMETHASONE BY PKC ACTIVATION OR CD28 TRIGGERING, Cellular immunology, 156(2), 1994, pp. 438-447
Citations number
30
Categorie Soggetti
Cytology & Histology",Immunology
Journal title
ISSN journal
00088749
Volume
156
Issue
2
Year of publication
1994
Pages
438 - 447
Database
ISI
SICI code
0008-8749(1994)156:2<438:AOTSEO>2.0.ZU;2-0
Abstract
The suppressive effect of the glucocorticoid dexamethasone (DEX) on pu rified CD4(+) T cells was found to depend on the activation pathway. I n contrast to anti-CD3- or PHA-induced T cell proliferation, the alter native pathway of T cell activation, i.e., through anti-CD2 and anti-C D28, appeared largely resistant to DEX. By titrating anti-CD28 or the protein kinase C (PKC) activator PMA in the DEX-sensitive systems, it was demonstrated that inhibition by DEX could be abrogated by enhancin g the CD28 signal or by stimulation of the PKC-dependent pathway. Supr aoptimal concentrations of PMA were inhibitory for proliferation and t his effect was partly prevented by DEX. These data suggest that the ou tcome of the effect of DEX on CD4(+) T cells is dependent on the activ ation pathway, in particular the role and composition of the transcrip tion factor AP-1. (C) 1994 Academic Press, Inc.